Laboratory findings and a combined multifactorial approach to predict death in critically ill patients with COVID-19: a retrospective study

Epidemiol Infect. 2020 Jun 30:148:e129. doi: 10.1017/S0950268820001442.

Abstract

To describe the laboratory findings of cases of death with coronavirus disease 2019 (COVID-19) and to establish a scoring system for predicting death, we conducted this single-centre, retrospective, observational study including 336 adult patients (≥18 years old) with severe or critically ill COVID-19 admitted in two wards of Union Hospital, Tongji Medical College, Huazhong University of Science and Technology in Wuhan, who had definite outcomes (death or discharge) between 1 February 2020 and 13 March 2020. Single variable and multivariable logistic regression analyses were performed to identify mortality-related factors. We combined multiple factors to predict mortality, which was validated by receiver operating characteristic curves. As a result, in a total of 336 patients, 34 (10.1%) patients died during hospitalisation. Through multivariable logistic regression, we found that decreased lymphocyte ratio (Lymr, %) (odds ratio, OR 0.574, P < 0.001), elevated blood urea nitrogen (BUN) (OR 1.513, P = 0.009), and raised D-dimer (DD) (OR 1.334, P = 0.002) at admission were closely related to death. The combined prediction model was developed by these factors with a sensitivity of 100.0% and specificity of 97.2%. In conclusion, decreased Lymr, elevated BUN, and raised DD were found to be in association with death outcomes in critically ill patients with COVID-19. A scoring system was developed to predict the clinical outcome of these patients.

Keywords: Blood urea nitrogen (BUN); D-dimer (DD); coronavirus disease 2019 (COVID-19); death; lymphocyte ratio.

Publication types

  • Observational Study

MeSH terms

  • Age Factors
  • Aged
  • Area Under Curve
  • Blood Chemical Analysis
  • Blood Urea Nitrogen
  • C-Reactive Protein / analysis
  • COVID-19
  • Causality
  • Coronavirus Infections / blood*
  • Coronavirus Infections / complications
  • Coronavirus Infections / epidemiology
  • Coronavirus Infections / mortality*
  • Critical Illness
  • Female
  • Fibrin Fibrinogen Degradation Products / analysis
  • Humans
  • Logistic Models
  • Lymphocyte Count
  • Male
  • Middle Aged
  • Pandemics
  • Pneumonia, Viral / blood*
  • Pneumonia, Viral / complications
  • Pneumonia, Viral / epidemiology
  • Pneumonia, Viral / mortality*
  • ROC Curve
  • Respiration, Artificial
  • Retrospective Studies

Substances

  • Fibrin Fibrinogen Degradation Products
  • fibrin fragment D
  • C-Reactive Protein